AU2008319177B2 - Lantibiotics from bifidobacterium longum and uses thereof - Google Patents

Lantibiotics from bifidobacterium longum and uses thereof Download PDF

Info

Publication number
AU2008319177B2
AU2008319177B2 AU2008319177A AU2008319177A AU2008319177B2 AU 2008319177 B2 AU2008319177 B2 AU 2008319177B2 AU 2008319177 A AU2008319177 A AU 2008319177A AU 2008319177 A AU2008319177 A AU 2008319177A AU 2008319177 B2 AU2008319177 B2 AU 2008319177B2
Authority
AU
Australia
Prior art keywords
seq
lantibiotic
microbe
amino acid
polypeptide
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
AU2008319177A
Other languages
English (en)
Other versions
AU2008319177A1 (en
Inventor
Ju-Hoon Lee
Daniel J. O'sullivan
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of Minnesota System
Original Assignee
University of Minnesota Twin Cities
University of Minnesota System
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of Minnesota Twin Cities, University of Minnesota System filed Critical University of Minnesota Twin Cities
Publication of AU2008319177A1 publication Critical patent/AU2008319177A1/en
Application granted granted Critical
Publication of AU2008319177B2 publication Critical patent/AU2008319177B2/en
Ceased legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N63/00—Biocides, pest repellants or attractants, or plant growth regulators containing microorganisms, viruses, microbial fungi, animals or substances produced by, or obtained from, microorganisms, viruses, microbial fungi or animals, e.g. enzymes or fermentates
    • A01N63/50—Isolated enzymes; Isolated proteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicinal Chemistry (AREA)
  • Virology (AREA)
  • Microbiology (AREA)
  • Environmental Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Dentistry (AREA)
  • Plant Pathology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Pest Control & Pesticides (AREA)
  • Biotechnology (AREA)
  • Agronomy & Crop Science (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Cosmetics (AREA)
AU2008319177A 2007-07-20 2008-07-18 Lantibiotics from bifidobacterium longum and uses thereof Ceased AU2008319177B2 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US96137407P 2007-07-20 2007-07-20
US60/961,374 2007-07-20
PCT/US2008/070511 WO2009058440A2 (en) 2007-07-20 2008-07-18 Lantibiotics from bifidobacterium longum and uses thereof

Publications (2)

Publication Number Publication Date
AU2008319177A1 AU2008319177A1 (en) 2009-05-07
AU2008319177B2 true AU2008319177B2 (en) 2012-07-05

Family

ID=40432080

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2008319177A Ceased AU2008319177B2 (en) 2007-07-20 2008-07-18 Lantibiotics from bifidobacterium longum and uses thereof

Country Status (9)

Country Link
US (2) US7960505B2 (enExample)
EP (1) EP2176284B1 (enExample)
JP (1) JP2010534063A (enExample)
KR (1) KR20100043252A (enExample)
AU (1) AU2008319177B2 (enExample)
CA (1) CA2693307A1 (enExample)
DK (1) DK2176284T3 (enExample)
NZ (1) NZ582529A (enExample)
WO (1) WO2009058440A2 (enExample)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20100043252A (ko) 2007-07-20 2010-04-28 리전츠 오브 더 유니버스티 오브 미네소타 비피도박테리움 롱검으로부터의 랜티바이오틱 및 이의 용도
WO2012058557A2 (en) * 2010-10-28 2012-05-03 The Procter & Gamble Company Personal care compositions comprising a pyrithione and an iron chelator
EP2532232A1 (en) 2011-06-10 2012-12-12 InterMed Discovery GmbH Long chain glycolipids useful to avoid perishing or microbial contamination of materials
AU2013226404B2 (en) 2012-02-27 2017-11-30 Oragenics, Inc. Replacement therapy for dental caries
US9573980B2 (en) 2013-03-15 2017-02-21 Spogen Biotech Inc. Fusion proteins and methods for stimulating plant growth, protecting plants from pathogens, and immobilizing Bacillus spores on plant roots
GB201409451D0 (en) 2014-05-28 2014-07-09 Ipabc Ltd Antimicrobial preparations, methods for preparing the same and uses thereof to combat microorganisms
WO2016180928A1 (en) * 2015-05-12 2016-11-17 Novozymes A/S Bacillus licheniformis host cell with deleted lantibiotic gene(s)
CN106188253B (zh) * 2016-08-26 2020-08-18 上海交通大学 抗菌肽Lexapeptide及其制备方法和用途
US10738338B2 (en) 2016-10-18 2020-08-11 The Research Foundation for the State University Method and composition for biocatalytic protein-oligonucleotide conjugation and protein-oligonucleotide conjugate
CN108170988B (zh) * 2018-01-23 2021-01-01 成都希盟泰克科技发展有限公司 基于bim技术的隧道开挖三台阶七步方法
CN113905715B (zh) 2019-06-28 2025-04-15 宝洁公司 光增强处理方法
US20230226127A1 (en) * 2020-06-19 2023-07-20 Healthy Cow Corporation Ready-to-use probiotic compositions and uses thereof
JP7570216B2 (ja) * 2020-11-30 2024-10-21 株式会社ヤクルト本社 ヒト腸内に長期定着する微生物のスクリーニング方法

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5260271A (en) * 1988-06-22 1993-11-09 Applied Microbiology, Inc. Nisin compositions for use as enhanced broad range bactericides
US6964760B2 (en) 1997-06-10 2005-11-15 University Of Florida Research Foundation Antimicrobial polypeptide, nucleic acid, and methods of use
WO2001098516A2 (en) * 2000-06-19 2001-12-27 Regents Of The University Of Minnesota Siderophores-producing bifidobacteria thereby and uses thereof
CA2404356A1 (en) 2002-09-18 2004-03-18 Canadian Inovatech Inc. Gram-positive antibacterial composition and method for use
AU2003296937A1 (en) 2002-12-10 2004-06-30 Biosynexus Incorporated Topical anti-infective formulations
US7326683B2 (en) * 2004-05-06 2008-02-05 Molichem Medicines, Inc. Treatment of membrane-associated diseases and disorders using lantibiotic containing compositions
US7479481B2 (en) * 2004-05-06 2009-01-20 Molichem Medicines, Inc. Treatment of ocular diseases and disorders using lantibiotic compositions
US20060024414A1 (en) * 2004-07-30 2006-02-02 Kraft Foods Holdings, Inc. Methods for preserving food products
KR20100043252A (ko) 2007-07-20 2010-04-28 리전츠 오브 더 유니버스티 오브 미네소타 비피도박테리움 롱검으로부터의 랜티바이오틱 및 이의 용도

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
Salah, F. A. & El-Sayed, E. M. (2004) Egyptian Conference for Dairy Science and Technology, 9th, Cairo, Egypt. *
Servin A. L. (2004) FEMS. Microbiol. Rev., 28:405-440 *

Also Published As

Publication number Publication date
KR20100043252A (ko) 2010-04-28
JP2010534063A (ja) 2010-11-04
AU2008319177A1 (en) 2009-05-07
US8933193B2 (en) 2015-01-13
US20090068121A1 (en) 2009-03-12
CA2693307A1 (en) 2009-05-07
EP2176284A2 (en) 2010-04-21
WO2009058440A3 (en) 2009-09-24
EP2176284B1 (en) 2013-09-04
US20110305763A1 (en) 2011-12-15
NZ582529A (en) 2012-01-12
US7960505B2 (en) 2011-06-14
DK2176284T3 (da) 2013-10-14
WO2009058440A2 (en) 2009-05-07

Similar Documents

Publication Publication Date Title
US7960505B2 (en) Lantibiotics and uses thereof
EP3377517A1 (en) Bacteriocin composition and method
EP3219325B1 (en) Variants of the lantibiotic mu1140 and other lantibiotics with improved pharmacological properties and structural features
Nes et al. Antimicrobial components of lactic acid bacteria
CA3060503A1 (en) Lantibiotics, lantibiotic-producing bacteria, compositions and methods of production and use thereof
AU2017296061B2 (en) Lantibiotic variants and uses thereof
Nes et al. Novel developments in bacteriocins from lactic acid bacteria
Collins et al. Antimicrobials from lactic acid bacteria and their potential applications
Nabizadeh et al. Bacteriocins and bacteriocin-like compounds synthesized by lactic acid bacteria
Banerjee et al. Bacteriocins: Potential usage and mechanism of action
US20230381249A1 (en) Probiotic strain for countering caries pathogens
JP2022545085A (ja) ガイド抗菌ペプチドのプロバイオティクス送達
Kumar LANTIBIOTICS A NOVEL ANTIMICROBIAL AGENTS: A REVIEW.
Papadimitriou et al. Fighting Off Human Infections
US20260092082A1 (en) Antimicrobial peptide halymorin variants and methods of using the same
Oladipo et al. Bioprotective potential of bacteriocinogenic Enterococcus gallinarum strains isolated from some Nigerian fermented foods, and of their bacteriocins
Villa et al. The Case of Lipid II: The Achilles’ Heel of Bacteria
WO2014140391A1 (es) Uso de la garvicina a como producto antimicrobiano
Wang Selection of Lactic Acid Bacteria and Their Metabolites for Preventing and Treating Infections
Fen Isolation, Purification and Mode of Action of Antimicrobial Peptides Produced by Lactic Acid Bacteria of Dairy Origin
KR20230160541A (ko) 수성 이상계 시스템을 이용한 박테리오신 생산 방법

Legal Events

Date Code Title Description
FGA Letters patent sealed or granted (standard patent)
MK14 Patent ceased section 143(a) (annual fees not paid) or expired